TY - JOUR
T1 - Nicotinic Receptors in the Brainstem Ascending Arousal System in SIDS With Analysis of Pre-natal Exposures to Maternal Smoking and Alcohol in High-Risk Populations of the Safe Passage Study
AU - PASS Network
AU - Vivekanandarajah, Arunnjah
AU - Nelson, Morgan E.
AU - Kinney, Hannah C.
AU - Elliott, Amy J.
AU - Folkerth, Rebecca D.
AU - Tran, Hoa
AU - Cotton, Jacob
AU - Jacobs, Perri
AU - Minter, Megan
AU - McMillan, Kristin
AU - Duncan, Jhodie R.
AU - Broadbelt, Kevin G.
AU - Schissler, Kathryn
AU - Odendaal, Hein J.
AU - Angal, Jyoti
AU - Brink, Lucy
AU - Burger, Elsie H.
AU - Coldrey, Jean A.
AU - Dempers, Johan
AU - Boyd, Theonia K.
AU - Fifer, William P.
AU - Geldenhuys, Elaine
AU - Groenewald, Coen
AU - Holm, Ingrid A.
AU - Myers, Michael M.
AU - Randall, Bradley
AU - Schubert, Pawel
AU - Sens, Mary Ann
AU - Wright, Colleen A.
AU - Roberts, Drucilla J.
AU - Nelsen, Laura
AU - Wadee, Shabbir
AU - Zaharie, Dan
AU - Haynes, Robin L.
N1 - Funding Information:
The PASS Network is solely responsible for the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The following researchers compose the PASS Network: PASS Steering Committee Chair (University of Texas Medical Branch): Gary DV Hankins, MD Data Coordinating & Analysis Center (DM-STAT, Inc.): PI: Kimberly A. Dukes, Ph.D; Co-PI: Lisa M. Sullivan, Ph.D; Biostatistics: Tara Tripp, MA; Fay Robinson, MPH; Cheri Raffo, MPH; Project Management/Regulatory Affairs: Julie M. Petersen, MPH; Rebecca A. Young, MPH; Statistical Programming/Data Management: Cindy Mai, BA; Elena Grillo, MBA, BS, BBA; Data Management/Information Technology: Travis Baker, BS; Patti Folan; Gregory Toland, MS; Michael Carmen, MS Developmental Biology & Pathology Center (Children's Hospital Boston): PI: Hannah C. Kinney, MD; Assistant Director: Robin L. Haynes, Ph.D; Co-investigators: Rebecca D. Folkerth, MD; Ingrid A. Holm, MD; Theonia Boyd, MD; David S. Paterson, Ph.D; Hanno Steen, Ph.D; Kyriacos Markianos, Ph.D; Drucilla Roberts, MD; Kevin G. Broadbelt, Ph.D; Richard G. Goldstein, MD; Laura L. Nelsen, MD; Jacob Cotton, BS; Perri Jacobs, BS Comprehensive Clinical Site Northern Plains (Sanford Research): PI: Amy J. Elliott, Ph.D; Co-PI: Larry Burd, Ph.D; Co-investigators: Jyoti Angal, MPH; Elizabeth Berg, RN; Jessica Gromer, RN; H. Eugene Hoyme, MD; Margaret Jackson, BA; Luke Mack, MA; Bethany Norton, MA; Bradley B. Randall, MD; Mary Ann Sens, MD; Liz Swenson, RN; Deborah Tobacco, MA; Peter Van Eerden, MD Comprehensive Clinical Site South Africa (Stellenbosch University): PI: Hendrik Odendaal, MBChB, FRCOG, MD; Co-PI: Colleen Wright, MD, FRCPath, Ph.D; Co-Investigators: Lut Geerts, MD, MRCOG; Greetje de Jong, MBChB, MMed, MD; Pawel Schubert, FCPath (SA) MMed; Shabbir Wadee, MMed; Johan Dempers, FCFor Path (SA); Elsie Burger, FCFor Path (SA), MMed Forens Path; Janetta Harbron, PhD; Co-investigator & Project Manager: Coen Groenewald, MBChB, MMed, FCOG, M Comm; Project Manager: Erna Carstens, RN Physiology Assessment Center (Columbia University): Co-PIs: William Fifer, Ph.D; Michael Myers, Ph.D; Co-investigators: Joseph Isler, Ph.D; Yvonne Sininger, Ph.D; Project Management: J. David Nugent, MA; Carmen Condon, BA; Data Analysis: Margaret C. Shair, BA; Tracy Thai, MA NIH Project Scientists: Marian Willinger, Ph.D (NICHD); Dale Hereld, MD, Ph.D (NIAAA); Howard J. Hoffman, MA (NIDCD); Chuan-Ming Li, MD, Ph.D (NIDCD) The authors gratefully acknowledge the cooperation of the study participants, PASS investigators and members of the NICHD Advisory and Safety Monitoring Board: Elizabeth Thom, Ph.D (Chair); The Reverend Phillip Cato, Ph.D; James W Collins, Jr, MD, MPH; Terry Dwyer, MD, MPH; George Macones, MD; Philip A May, Ph.D; Richard M Pauli, MD, Ph.D; Raymond W Redline, MD; and Michael Varner, MD. Additional Acknowledgments: the following individuals made significant contributions to the research and warrant recognition: DCAC: Idania Ramirez, MPH; Laura Spurchise, MPH; Jamie Collins, Ph.D; Derek Petersen, BS PAC: Johnston T. Grier, BA; Emilia F. Vignola, BA; Joseph J Violaris, BA DBPC: Richard Belliveau We would like to acknowledge Dr. Eugene Nattie and Elisabeth Haas for the careful review of the data and the manuscript. We would like to acknowledge Molly Riehs for administrative assistance with manuscript and database organization. Funding. The research reported in this publication was supported by the National Institutes of Health (NIH) grants U01HD055154, U01HD045935, U01HD055155, U01HD045991, and U01AA016501 funded by the National Institute on Alcohol Abuse and Alcoholism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute on Deafness and Other Communication Disorders. AV was supported on a fellowship by River's Gift (Victoria, Australia) and the Harvard University Mobility Scheme awarded by the University of Sydney (Sydney, Australia). JRD was supported by the First Candle/SIDS alliance and CJ Martin Overseas Fellowship (National Health and Medical Research Council of Australia).
Publisher Copyright:
© Copyright © 2021 Vivekanandarajah, Nelson, Kinney, Elliott, Folkerth, Tran, Cotton, Jacobs, Minter, McMillan, Duncan, Broadbelt, Schissler, Odendaal, Angal, Brink, Burger, Coldrey, Dempers, Boyd, Fifer, Geldenhuys, Groenewald, Holm, Myers, Randall, Schubert, Sens, Wright, Roberts, Nelsen, Wadee, Zaharie, Haynes and PASS Network.
PY - 2021/3/10
Y1 - 2021/3/10
N2 - Pre-natal exposures to nicotine and alcohol are known risk factors for sudden infant death syndrome (SIDS), the leading cause of post-neonatal infant mortality. Here, we present data on nicotinic receptor binding, as determined by 125I-epibatidine receptor autoradiography, in the brainstems of infants dying of SIDS and of other known causes of death collected from the Safe Passage Study, a prospective, multicenter study with clinical sites in Cape Town, South Africa and 5 United States sites, including 2 American Indian Reservations. We examined 15 pons and medulla regions related to cardiovascular control and arousal in infants dying of SIDS (n = 12) and infants dying from known causes (n = 20, 10 pre-discharge from time of birth, 10 post-discharge). Overall, there was a developmental decrease in 125I-epibatidine binding with increasing postconceptional age in 5 medullary sites [raphe obscurus, gigantocellularis, paragigantocellularis, centralis, and dorsal accessory olive (p = 0.0002–0.03)], three of which are nuclei containing serotonin cells. Comparing SIDS with post-discharge known cause of death (post-KCOD) controls, we found significant decreased binding in SIDS in the nucleus pontis oralis (p = 0.02), a critical component of the cholinergic ascending arousal system of the rostral pons (post-KCOD, 12.1 ± 0.9 fmol/mg and SIDS, 9.1 ± 0.78 fmol/mg). In addition, we found an effect of maternal smoking in SIDS (n = 11) combined with post-KCOD controls (n = 8) on the raphe obscurus (p = 0.01), gigantocellularis (p = 0.02), and the paragigantocellularis (p = 0.002), three medullary sites found in this study to have decreased binding with age and found in previous studies to have abnormal indices of serotonin neurotransmission in SIDS infants. At these sites, 125I-epibatidine binding increased with increasing cigarettes per week. We found no effect of maternal drinking on 125I-epibatidine binding at any site measured. Taken together, these data support changes in nicotinic receptor binding related to development, cause of death, and exposure to maternal cigarette smoking. These data present new evidence in a prospective study supporting the roles of developmental factors, as well as adverse exposure on nicotinic receptors, in serotonergic nuclei of the rostral medulla—a finding that highlights the interwoven and complex relationship between acetylcholine (via nicotinic receptors) and serotonergic neurotransmission in the medulla.
AB - Pre-natal exposures to nicotine and alcohol are known risk factors for sudden infant death syndrome (SIDS), the leading cause of post-neonatal infant mortality. Here, we present data on nicotinic receptor binding, as determined by 125I-epibatidine receptor autoradiography, in the brainstems of infants dying of SIDS and of other known causes of death collected from the Safe Passage Study, a prospective, multicenter study with clinical sites in Cape Town, South Africa and 5 United States sites, including 2 American Indian Reservations. We examined 15 pons and medulla regions related to cardiovascular control and arousal in infants dying of SIDS (n = 12) and infants dying from known causes (n = 20, 10 pre-discharge from time of birth, 10 post-discharge). Overall, there was a developmental decrease in 125I-epibatidine binding with increasing postconceptional age in 5 medullary sites [raphe obscurus, gigantocellularis, paragigantocellularis, centralis, and dorsal accessory olive (p = 0.0002–0.03)], three of which are nuclei containing serotonin cells. Comparing SIDS with post-discharge known cause of death (post-KCOD) controls, we found significant decreased binding in SIDS in the nucleus pontis oralis (p = 0.02), a critical component of the cholinergic ascending arousal system of the rostral pons (post-KCOD, 12.1 ± 0.9 fmol/mg and SIDS, 9.1 ± 0.78 fmol/mg). In addition, we found an effect of maternal smoking in SIDS (n = 11) combined with post-KCOD controls (n = 8) on the raphe obscurus (p = 0.01), gigantocellularis (p = 0.02), and the paragigantocellularis (p = 0.002), three medullary sites found in this study to have decreased binding with age and found in previous studies to have abnormal indices of serotonin neurotransmission in SIDS infants. At these sites, 125I-epibatidine binding increased with increasing cigarettes per week. We found no effect of maternal drinking on 125I-epibatidine binding at any site measured. Taken together, these data support changes in nicotinic receptor binding related to development, cause of death, and exposure to maternal cigarette smoking. These data present new evidence in a prospective study supporting the roles of developmental factors, as well as adverse exposure on nicotinic receptors, in serotonergic nuclei of the rostral medulla—a finding that highlights the interwoven and complex relationship between acetylcholine (via nicotinic receptors) and serotonergic neurotransmission in the medulla.
KW - acetylcholine
KW - arousal
KW - cardiorespiratory
KW - medulla oblongata
KW - mesopontine tegmentum
KW - serotonin
UR - http://www.scopus.com/inward/record.url?scp=85103020919&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103020919&partnerID=8YFLogxK
U2 - 10.3389/fneur.2021.636668
DO - 10.3389/fneur.2021.636668
M3 - Article
C2 - 33776893
AN - SCOPUS:85103020919
SN - 1664-2295
VL - 12
JO - Frontiers in Neurology
JF - Frontiers in Neurology
M1 - 636668
ER -